International Business Times: Scientists Find Harmless Strain of E.Coli Bacteria Provides Protection Against its Lethal Cousin
UC researchers hope to find a treatment for Hamburger E.coli
A new study by researchers from the University of Cincinnati College of Medicine offers evidence that a harmless strain of E.coli bacteria may offer protection from a lethal one. According to the study, Nissle—a strain of E.Coli that is used as a probiotic was found to protect human intestinal organoids (HIOs) from a pathogenic strain known as enterohemorrhagic E. coli or more commonly as hamburger E.coli. Alison Weiss, PhD, professor, and Suman Pradhan, PhD, research associate, both in the UC Department of Molecular Genetics, Biochemistry and Microbiology were authors of the study.
Read the full interview in International Business Times
Learn more about the research of Dr. Weiss and Dr. Pradhan.
Other media also covered the research findings and they include:
Featured photo of hamburgers courtesy of Unsplash.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.